or Try an Advanced Search...

    Seth Lederman Stocks List

    Symbol Grade Name % Change
    VCNX F Vaccinex, Inc. 5.73
    TNXP F Tonix Pharmaceuticals Holding Corp. -4.13
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Antibody Autoimmune Disorders Biology Biotechnology Cancer Clinical Development Degenerative Disease Disorders Drugs Fibromyalgia Headache Health Sciences Human Monoclonal Antibodies Immune Disorders Immune System Immunology Melanoma Monoclonal Antibodies Multiple Sclerosis

    Seth Lederman Stocks Recent News

    Date Stock Title
    Nov 1 TNXP Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
    Oct 31 VCNX Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain
    Oct 29 TNXP Tonix Pharmaceuticals to Present at BIO-Europe® 2024
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Antibody Autoimmune Disorders Biology Biotechnology Cancer Clinical Development Degenerative Disease Disorders Drugs Fibromyalgia Headache Health Sciences Human Monoclonal Antibodies Immune Disorders Immune System Immunology Melanoma Monoclonal Antibodies Multiple Sclerosis
    Seth Lederman

    Seth Lederman (born July 30, 1957) is a physician, scientist and specialty pharmaceuticals entrepreneur. He is a co-founder and the current President and Chairman of Tonix Pharmaceuticals, a specialty pharmaceutical product development and commercialization company.

    More about Seth Lederman
    Browse All Tags